Patient Corner

Anatomical Illustrations

More

Latest drug updates

  • 24 Aug 2017 - Drug Updates

Revised recommendations for use of adrenaline auto-injectors post European review

Patients should carry 2 adrenaline auto-injectors at all times.

Read more
  • 23 Aug 2017 - Drug Updates

Local and systemic administration of corticosteroids: risk of central serous chorioretinopathy

Report any blurred vision or other visual disturbances during corticosteroid treatment.

Read more
  • 23 Aug 2017 - Drug Updates

Ibrutinib (Imbruvica▼): Reported cases of ventricular tachyarrhythmia and risk of hepatitis B reactivation and opportunistic infections

Discontinue ibrutinib in patients who develop symptoms suggestive of ventricular arrhythmia and be aware of the risk of hepatitis B virus reactivation and opportunistic infections.

Read more
  • 31 Jul 2017 - Drug Updates

Daclizumab (Zinbryta▼) in multiple sclerosis: Review patients for liver function currently on treatment

Initiate daclizumab in restricted groups of patients with limited treatment options and closely monitor liver function.

Read more
  • 28 Jul 2017 - Drug Updates

Bendamustine (Levact): Increased mortality when used in combination treatment outside the approved indications

Closely monitor patients for opportunistic infections as well as cardiac, neurological, and respiratory adverse events.

Read more
  • 28 Jul 2017 - Drug Updates

Nivolumab (Opdivo▼), pembrolizumab (Keytruda▼): Risk of graft rejection

Consider the benefit of treatment with nivolumab or pembrolizumab versus the risk of possible organ transplant rejection for each patient.

Read more
  • 27 Jun 2017 - Drug Updates

Denosumab (Prolia, Xgeva▼): Risk of osteonecrosis of jaw and external auditory canal

Advise patients to report any ear pain, discharge from ear, or an ear infection during denosumab treatment.

Read more
  • 27 Jun 2017 - Drug Updates

Brimonidine gel (Mirvaso): Risk of cardiovascular events if applied to damaged skin

Advise patients not to apply brimonidine gel to irritated or damaged skin.

Read more
  • 27 Jun 2017 - Drug Updates

Yellow Card Scheme Website: Report any side effects or safety concerns with e-cigarettes and e-liquids

Information on Yellow Card Scheme Website can aid in identifying unrecognised side effects and can thereby help to support the safety of e-cigarettes.

Read more
  • 27 Jun 2017 - Drug Updates

Restrictions to manage the risk for misuse of pseudoephedrine and ephedrine to be continued

Sale and supply of these products should be done under supervision of pharmacist or suitably trained pharmacy staff.

Read more